Quest Diagnostics® and Cleveland HeartLab® are working across boundaries and the care continuum to bring you more advanced cardiovascular solutions and services.
Together with One Brave Idea™ we hosted an expert-led panel discussion at the American Heart Association (AHA) Scientific Sessions in November.
Working across industries to reimagine the future
Moving New Diagnostics into the Clinic in the 21st Century explores the reasons traditional biomarkers for coronary heart disease (CHD) are insufficient, and why we must work across boundaries, old assumptions, and disciplines to reimagine the future in order to prevent, detect, and treat CHD.
Dr. Calum MacRae
Lead, One Brave Idea
Dr. Marc S. Penn
Co-Founder and Chief Medical Officer, Cleveland HeartLab, Quest Diagnostics
Dr. Paul Ridker
Director of the Center for Cardiovascular Disease Prevention and the Eugene Braunwald Professor of Medicine, Brigham and Women’s Hospital
Dr. Naeem Khan
Vice President US Medical Affairs, Cardiovascular and Metabolic Diseases, AstraZeneca
Dr. Rahul Deo
Chief Data Scientist, One Brave Idea
In the news: Advancing cardiac care
Advancing care across the cardiometabolic continuum
Learn more about our advanced cardiovascular testing—solutions that will take you beyond traditional biomarker testing to gain deeper insight and uncover hidden risk.